Advertisement

Topics

Companies Related to "Longitudinal Study of Asymptomatic Rotator Cuff Tears" [Most Relevant Company Matches] RSS

04:47 EDT 16th August 2018 | BioPortfolio

Here are the most relevant search results for "Longitudinal Study of Asymptomatic Rotator Cuff Tears" found in our extensive corporate database of over 50,000 company records.

Showing "Longitudinal Study Asymptomatic Rotator Cuff Tears" Companies 1–25 of 622

Extremely Relevant

Rotation Medical, Inc.

Rotation Medical was founded in 2009 and is committed to advancing the treatment of rotator cuff disease through the development of a proprietary, minimally invasive rotator cuff implant system. The system combines a collagen scaffold that is affixed to the affected tendon using disposable, arthroscopic instruments that are designed to enable quick, reprod...


Rotation Medical Inc.

Rotator cuff damage is the most common source of shoulder pain, affecting more than 4 million people annually in the U.S. Traditional approaches to treating degenerate or torn rotator cuffs often do not address the poor quality of the underlying tendon tissue, and a significant number of these tendons, after standard treatment, either degenerate further an...

Tissue Science Laboratories plc

Formed in 1996 Tissue Science Laboratories plc (TSL) is an independent medical device company dedicated to the research, development and marketing of tissue implant products. TSL's first product, Permacol™ surgical implant was approved for use in the EU in 1997. In September 1999 TSL signed its first worldwide distribution agreement with CR BARD Inc for surgical applications in the fields of uro...


Relevant

KFx Medical Corporation

KFx Medical Corporation, a privately held company headquartered in Carlsbad, CA, develops industry-changer sports medicine procedures and products for orthopedic surgeons. Founded in 2003, KFx Medical has brought to market innovative tissue fixation implants and bone anchors used in a variety of orthopedic surgical procedures performed on the shoulder, kne...

Tornier, Inc. / LifeCell Corporation

Tornier develops and markets orthopaedic medical devices designed to restore function and return patients to an active and healthy lifestyle. The company's innovative extremity and sports products include the Aequalis® line of shoulder arthroplasty prostheses; the Salto™ and Salto Talaris™ total ankle prostheses; a broad portfolio of foot and hand ...

GPRD Exellence in Public Health Research

The GPRD Division is a dedicated multi-disciplinary team based at the Medicines & Healthcare products Regulatory Agency (MHRA) in London who operate the General Practice Research Database, the GOLD standard of longitudinal anonymised patient databases from primary care.Our mission is simple...to promote and protect public health by establishing the GPRD as the premier source of longitudinal patien...

Fairbanks Institute for Healthy Communities

The Fairbanks Institute for Healthy Communities is a not-for-profit organization working to improve community health by conducting longitudinal cohort studies of the Central Indiana population (The Indiana Health Study) that will enable research that speeds the development of personalized medicine and improvements in patient outcomes. The Fairbanks Institu...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

Healthy Life Screening

Located in Akron, Ohio, Healthy Life Screening was started in 2006 offering a range of preventive health screens on asymptomatic individuals for the presence of cardiovascular disease. The screening consists of five tests: left ventricle dysfunction, peripheral artery disease, abdominal aortic, carotid artery screening (including carotid intima-media thick...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

TABS Group, Inc.

The 2010 TABS Group Vitamin Study was conducted among 1,000 representative respondents aged 18-75 in the TNS panel. The responses were combined with TABS Group's proprietary modeling capabilities to derive the market size estimates for the Vitamin Category. The study was fielded in May 2010, and it replicated a study that was completed in January 2008. TABS Group is a leading provider of resear...

nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Nerites

Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices. Properties can be "tuned" to fit each application. The technology was described with a cover ar...

PharMetrics, Inc.

PharMetrics, Inc. is a leading provider of healthcare market insights to the pharmaceutical, biotech, medical device, and health plan sectors of the market. All of our market insights are provided by virtue of our unique longitudinal database of patient-level information. PharMetrics strictly adheres to the requirements of the Health Insurance Portability and Accountability Act (HIPAA).

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a transplant. The first transplantation was carried out in September and four transplantations have thus now been carried out at four centres. A fifth centre, Duke University, has been ...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...


More From BioPortfolio on "Longitudinal Study of Asymptomatic Rotator Cuff Tears"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks